DrugPatentWatch Database Preview
Drugs in Development Information for Hepatitis A Vaccine
Drug Development Status for Hepatitis A Vaccine: Sponsors, patents, clinical trial progress
Hepatitis A Vaccine is an investigational drug.
There have been 4 clinical trials for Hepatitis A Vaccine.
The most recent clinical trial was a Phase 2 trial, which was initiated on April 1st 2011.
The most common disease conditions in clinical trials are HIV Infections, Colonic Neoplasms, and Urinary Bladder Neoplasms. The leading clinical trial sponsors are National Institute of Allergy and Infectious Diseases (NIAID), National Cancer Institute (NCI), and MacroGenics.
There are thirteen US patents protecting this investigational drug and two hundred and fifty-two international patents.
Summary for Hepatitis A Vaccine
| US Patents | 13 |
| International Patents | 252 |
| US Patent Applications | 0 |
| WIPO Patent Applications | 0 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2011-04-01) |
| Vendors | 0 |
Recent Clinical Trials for Hepatitis A Vaccine
| Title | Sponsor | Phase |
|---|---|---|
| Phase 1 Study of MGD010 in Healthy Subjects | MacroGenics | Phase 1 |
| Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had Chemotherapy | National Cancer Institute (NCI) | Phase 2 |
| A Study to Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients | National Institute of Allergy and Infectious Diseases (NIAID) | N/A |
Clinical Trial Summary for Hepatitis A Vaccine
Top disease conditions for Hepatitis A Vaccine
Top clinical trial sponsors for Hepatitis A Vaccine
US Patents for Hepatitis A Vaccine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Hepatitis A Vaccine | See Pricing | Cell culture of hepatitis A virus | Merck & Co., Inc. (Rayway, NJ) | See Pricing |
| Hepatitis A Vaccine | See Pricing | Liquid formulations for proteinic pharmaceuticals | See Pricing | |
| Hepatitis A Vaccine | See Pricing | Cell culture of hepatitis A virus | Merck & Co., Inc. (Rahway, NJ) | See Pricing |
| Hepatitis A Vaccine | See Pricing | Chimeric hepatitis A vaccine | The United of America as represented by the Department of Health and Human Services (Washington, DC) | See Pricing |
| Hepatitis A Vaccine | See Pricing | Attenuated hepatitis a virus vaccine which grows in MRC-5 cells | The United States of America as represented by the Department of Health and Human Services (Washington, DC) | See Pricing |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Hepatitis A Vaccine
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Hepatitis A Vaccine | Australia | 5642396 | 2015-05-16 | See Pricing |
| Hepatitis A Vaccine | Canada | 2210996 | 2015-05-16 | See Pricing |
| Hepatitis A Vaccine | European Patent Office | 0813421 | 2015-05-16 | See Pricing |
| Hepatitis A Vaccine | World Intellectual Property Organization (WIPO) | 9636352 | 2015-05-16 | See Pricing |
| Hepatitis A Vaccine | Austria | 8409 | 1999-09-04 | See Pricing |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
